Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07699380
PHASE2

METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)

Sponsor: University of Washington

View on ClinicalTrials.gov

Summary

The study is a randomized, double-blind, parallel-group clinical trial to examine the effects of 24 weeks of oral AMX0035 (sodium phenylbutyrate + taurursodiol) versus placebo in 60 adults with Type 1 Diabetes (T1D) (n=30 per arm). Enrollment will be distributed equally between the University of Washington and Amsterdam University Medical Center/Diabetes Center Amsterdam. Participants will be recruited through diabetes research registries, local T1D clinics, and community outreach.

Key Details

Gender

All

Age Range

18 Years - 69 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2026-09

Completion Date

2029-12

Last Updated

2026-09-15

Healthy Volunteers

No

Interventions

DRUG

AMX0035

AMX0035 sachets

DRUG

Placebo

Placebo sachets

Locations (2)

University of Washington Medicine Diabetes Institute (UWMDI)

Seattle, Washington, United States

Amsterdam UMC

Amsterdam, Netherlands